öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£º³ØÏþÁá
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º336

ËùÊôԺУ£º¹ãÖÝÖÐÒ½Ò©´óѧ
ËùÊôԺϵ£º212µÚ¶þÁÙ´²Ò½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ѧ¿ÆÁìÓò
¿Æѧѧλ£º¶àάÁ¢ÌåϵÁÐÁÆ·¨ÌåϵÖÎÁƸε¨ÏµÍ³¼²²¡µÄÀíÂÛÓë»ù´¡Ñо¿
öλÔÓéÀֵǼÈë¿ÚÏÂÔØ... [Õ¹¿ª]


Ñо¿ÁìÓò£º ѧ¿ÆÁìÓò
¿Æѧѧλ£º¶àάÁ¢ÌåϵÁÐÁÆ·¨ÌåϵÖÎÁƸε¨ÏµÍ³¼²²¡µÄÀíÂÛÓë»ù´¡Ñо¿
öλÔÓéÀֵǼÈë¿ÚÏÂÔØѧλ£º¶àάÁ¢ÌåϵÁÐÁÆ·¨ÌåϵÖÎÁƸε¨ÏµÍ³¼²²¡µÄÁÙ´²Ó¦ÓÃÑо¿ [ÊÕÆð]




¸öÈ˼òÊö :
¸öÈ˼òÊö
1960Äê³öÉú£¬ºº×壬¹ã¶«Ê¡ÃûÖÐÒ½Ôº£¬ÁëÄÏÃûÒ½£¬Ö÷ÈÎҽʦ£¬½ÌÊÚ£¬²©Ê¿Ñо¿Éúµ¼Ê¦£¬È«¹úÃûÀÏÖÐҽѧÊõ¾­Ñé¼Ì³ÐÈË£¬¹ã¶«Ê¡Ê×ÅúÃûҽʦ³ÐÖ¸µ¼ÀÏʦ£¬ÖÐÒ½ÕÜѧ·ÃÎÊѧÕß¡£
Ö÷ÒªÈÙÓþ
¡°·öÕý½ºÄÒµÄÑÐÖÆ¡±»ñµÃÇຣʡ¿Æѧ¼¼ÊõÌü¡°Çຣʡ¿Æ¼¼³É¹ûÍê³ÉÕßÖ¤Ê顱
¡°×ÌÒõÇåÈÈ»¯ðö·¨ÖÎÁƾƾ«ÐԸβ¡¡±»ñµÃÇຣʡÎÀÉúÌü¡°¿ªÕ¹Ð¼¼Êõ¡¢ÐÂÒµÎñ¡¢Ð·½·¨£¬´ïµ½Ê¡ÄÚÏȽøˮƽ¡±
¡¶Ë³×ŽÚÆøÑø×Ô¼º¡·»ñ»ªÏÄҽѧ¿ÆÆÕ½±
¡°ÂýÐÔ±ûÐ͸ÎÑ×µÄÖÐÒ½Ö¤ºò¹æÂɼ°ÖÐÎ÷Ò½½áºÏÖÎÁÆ·½°¸¸ÉÔ¤µÄÁÙ´²Ñо¿¡±»ñÖйúÖÐÎ÷Ò½½áºÏѧ»á¿Æѧ¼¼ÊõÈýµÈ½±
¡°ÂýÐÔÒÒÐ͸ÎÑ×ÇáÖ¢¸ÎÏËά»¯µÄÖÐÒ½Ò©¸ÉÔ¤Ñо¿¡±»ñµÃ¹ã¶«Ê¡Ò©Ñ§»áҽԺҩѧ¿Æѧ¼¼Êõ½±Ò»µÈ½±

¿ÆÑй¤×÷ :
ѧÊõ¼æÖ°
ÔÚ¹ú¼Ò¼°Ê¡¼¶Ñ§ÊõÍÅÌåµ£ÈÎ40¶à¸öѧÊõÈÎÖ°£¬ÁоÙÈçÏ£º
¹ú¼ÒʳƷҩƷ¼à¶½¹ÜÀí¾ÖÐÂÒ©ÆÀÉóר¼Ò
¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾Ö¿Æ¼¼ÆÀÉóר¼Ò
¹ú¼Ò¿Æ¼¼²¿¿Æ¼¼ÆÀÉóר¼Ò¿â³ÉÔ±
¹ã¶«Ê¡±£½¡Ð­»áÊ×ϯר¼Ò¹ËÎÊ
¹ã¶«Ê¡±£½¡Ð­»á½¡¿µ·þÎñʾ·¶»ùµØÊ×ϯר¼Ò
ÖйúÃñ×åҽҩѧ»á´«È¾²¡öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±»á³¤
ÖйúÃñ×åҽҩѧ»á¸Î²¡öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±»á³¤
ÊÀ½çÖÐҽҩѧ»áÁªºÏ»á·½Ò©Á¿Ð§Ñо¿öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±»á³¤
ÖлªÖÐҽҩѧ»á·½Ò©Á¿Ð§Ñо¿·Ö»á¸±Ö÷ÈÎίԱ
ÖлªÖÐҽҩѧ»á¸Îµ¨²¡öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á¸±ÃØÊ鳤
¹ã¶«Ê¡Ò©Ñ§»áÖÐÒ½¸Î²¡ÓÃҩר¼ÒίԱ»áÖ÷ÈÎίԱ
¹ã¶«Ê¡±£½¡Ð­»á¸Î²¡öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áÖ÷ÈÎίԱ
¹ã¶«Ê¡Ò½Ñ§»á¸ÐȾ²¡öλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á³£ÎñίԱ
¹ã¶«Ê¡Ò½Ê¦Ð­»á¸ÐȾ²¡Ò½Ê¦·Ö»á³£ÎñίԱ

Ö÷ÒªÂÛÎÄ
·¢±íÎÄÕÂ160ƪ£¬ÁоÙÈçÏ£º
Xiao-lingChi*,Huan-mingXiao,Yu-baoXie,Gao-shuCai,Jun-minJiang,Guang-junTian,Mei-jieShi,Shu-duoWu,Peng-taoZhaoandHui-junChen.ProtocolofaprospectivestudyforthecombinationtreatmentofShu-Gan-jian-Pidecoctionandsteroidstandardtherapyinautoimmunehepatitispatients.BMCComplementaryandAlternativeMedicine2016,16:505(DOI10.1186/s12906-016-1486-1)£¨IF1.987£©
Xiao-LingChi,Mei-JieShi,Huan-MingXiao,Yu-BaoXie,andGao-ShuCai.ThescoremodelcontainedChinesemedicinesyndromeelementofbloodstasispresentedaabetterperformancecomparedtoAPRIandFIB4indiagnosingadvancedfibrosisinpatientswithChronicHepatitisB.Evidence-BasedcomplementaryandAlternativeMedicine(IF1.88)£¨Volume2016,ArticleID**,6pageshttp://dx.doi.org/10.1155/2016/**£©
XiaoHuanming,JiangJunmin,XieYubao,ShiMeijie,TianGuangjun,ZhaoPengtao,ZhangChaozhen,ChenHuijun,XuChanyuan,ChiXiaoling.ColonhydrotherapyplusTraditionalChineseMedicinetotreatnon-alcoholicfattyliverdisease:apilotstudy.JournalofTraditionalChineseMedicine.2017,June15,37(3):1-2(IF0.991)
4.XiaoL.Chi,HuanM.Xiao,YuB.Xie,JunM.Jiang,GuangJ.Tian,GaoS.Cai,ShuD.Wu,JieZ.Chen,MeiJ.Shi,ChaoZ.Zhang,PengT.Zhao,HuiJ.Chen,YingX.Li,HongC.Liang,ChanY.Xu.ProgressionofinitiallymildhepaticfibrosisinChronichepatitisBpatients:aprospectiverepeatliverbiopsystudy.HEPATOLOGY,2016,VOLUME63,NUMBER1(SUPPL):883A£¨IF11.711£©
лÓñ±¦£¬³ØÏþÁᣨͨѶ×÷Õߣ©£¬Ïô»ÀÃ÷£¬Ê©Ã·½ã£¬²Ì¸ßÊõ£¬Õų¯Õ飬·®ÕýÂ×.»ùÓÚÔËÆøѧ˵̽ÌÖ¶¡ÓÏÄê¸ÎÏËά»¯µÄ×ۺϷÀÖιæÂÉ.ÖлªÖÐÒ½Ò©ÔÓÖ¾£¬2017£¬32£¨6£©£º2449-2452
ÀèÓ¢ÏÍ£¬ÎâÏþ¾Õ£¬³ØÏþÁᣨͨѶ×÷Õߣ©£¬Ïô»ÀÃ÷£¬Ìï¹ã¿¡.˲ʱµ¯ÐÔ³ÉÏñ¼¼ÊõºÍѪÇåѧÆÀ·ÖÄ£ÐÍÓë¸ÎÏËά»¯³Ì¶ÈµÄÏà¹ØÐÔ[J].¹ã¶«Ò½Ñ§£¬2017£¬38£¨13£©£º1994-1997.
ʩ÷½ã£¬½¯¿¡Ãñ£¬²Ì¸ßÊõ£¬Ìï¹ã¿¡£¬Ð»Óñ±¦£¬Ïô»ÀÃ÷£¬ÕÔÅóÌΣ¬³Â»Ý¾ü£¬³ØÏþÁᣨͨѶ×÷Õߣ©.ÖÐÒ©¹à³¦Í˻Ʒ½¶ÔÖضȻÆð㻼ÕßÍË»Æ×÷ÓõÄÓ°Ïì[J].ÖÐÎ÷Ò½½áºÏ¸Î²¡ÔÓÖ¾£¬2016£¬26£¨3£©£º155-157.
ÀîÔóÅô£¬³ØÏþÁᣨͨѶ×÷Õߣ©£¬ÖÜÏþÁᣬÏô»ÀÃ÷.»ùÓڹż®ÕûÀíµÄÖ¬·¾¸ÎÀú´ú·½Ò©Ö¤ÖηÖÎö[J].ÖлªÖÐÒ½Ò©ÔÓÖ¾£¬2016£¬31£¨10£©£º4307-4308.
Õų¯Õ飬Ïô»ÀÃ÷£¬Ê©Ã·½ã£¬ÎºÔó»Ô£¬Íõ¼ÎºÀ£¬³ØÏþÁᣨͨѶ×÷Õߣ©.ÂýÐÔÒÒÐ͸ÎÑ×Âý²¡¹ÜÀíÖÐҽģʽ³õ̽[J].ÖÐÎ÷Ò½½áºÏ¸Î²¡ÔÓÖ¾£¬2016£¬26£¨3£©£º181-182+184.
Ïô»ÀÃ÷£¬Ð»Óñ±¦£¬Îâ»Ý¾ý£¬³ØÏþÁᣨͨѶ×÷Õߣ©.ºÍºÏÊèÑø·½ÖÎÁÆʵÑéÐÔ´óÊó¸ÎÏËά»¯µÄÁ¿Ð§¹ØϵÑо¿.ÁÉÄþÖÐÒ½Ò©´óѧѧ±¨£¬2016£¬18£¨4£©£º125-128
лÓñ±¦£¬Ïô»ÀÃ÷£¬Ê©Ã·½ã£¬³ØÏþÁᣨͨѶ×÷Õߣ©.¸ÎÏËά»¯µÄÖÐÒ½Ò©ÖÎÁƽøÕ¹[J].ʱÕä¹úÒ½¹úÒ©£¬2016£¬27£¨3£©£º703-706.
³ØÏþÁᣬÀèʤ£¬Ïô»ÀÃ÷£¬Õų¯Õ飬ÁõÑàÑ࣬κÔó»Ô£¬Íõ¼ÎºÀ£¬ÁõÀÖöÎ.69Àý×ÔÉíÃâÒßÐÔ¸ÎÑ×»¼ÕßÖÐÒ½ÌåÖÊÌصã·ÖÎö[J].ÖÐÒ½ÔÓÖ¾£¬2016£¬57£¨6£©£º492-495.
лÓñ±¦£¬³ØÏþÁᣨͨѶ×÷Õߣ©£¬Ïô»ÀÃ÷£¬Ê©Ã·½ã£¬²Ì¸ßÊõ£¬Õų¯Õ飬·®ÕýÂ×£¨Ö¸µ¼£©.´ÓÔËÆøѧ˵̽ÌÖ±ûÉêÄê¸ÎÏËά»¯µÄ×ۺϷÀÖιæÂÉ.ÖлªÖÐÒ½Ò©ÔÓÖ¾£¬2016£¬31£¨3£©£º766-769
³ØÏþÁᣬÏô»ÀÃ÷£¬Ð»Óñ±¦.ÁÙ´²ÖÐҽѧÉúËØÖÊÅàÑøµÄ˼¿¼Óëʵ¼ù.ºÚÁú½­½ÌÓý£¬2016£¬£¨1£©£º73-74
ÁõÑàÑ࣬³ØÏþÁᣨͨѶ×÷Õߣ©£¬Ð»Óñ±¦£¬Ïô»ÀÃ÷.ÊÜ¿ØË¥¼õ²ÎÊý¶Ô·Ç¾Æ¾«ÐÔÖ¬·¾¸Î²¡Àíѧ·Ö¶ÈµÄÕï¶Ï¼ÛÖµ.ÊÀ½ç»ªÈËÏû»¯ÔÓÖ¾£¬2015£¬£¨21£©£º5377-5382
Ïô»ÀÃ÷£¬³ØÏþÁᣨͨѶ×÷Õߣ©£¬½¯¿¡Ãñ£¬Ìï¹ã¿¡£¬Ð»Óñ±¦£¬ÕÔÅóÌΣ¬ÀèÓ¢ÏÍ£¬Ê©Ã·½ã£¬Õų¯Õ飬µËÑàÃÃ.´ÓÖÐÒ½ÍâÖÎÁÆ·¨µÄʵʩ̽Ë÷¸Î²¡×¨¿ÆÖÐÒ½ÌØÉ«ÓÅÊƽ¨Éè[J].ÖÐÒ½Ò©¹ÜÀíÔÓÖ¾£¬2015£¬23£¨20£©£º14-16.
³ØÏþÁᣬÏô»ÀÃ÷£¬Ð»Óñ±¦£¬Ê©Ã·½ã.»ùÓÚÖØ´ó¿ÆÑÐÏîĿ̽ÌÖÖÐÎ÷Ò½½áºÏҽѧÑо¿ÉúµÄÅàÑø.ÖлªÒ½Ñ§½ÌÓý̽Ë÷£¬2015£¬14£¨7£©£º698-701
³ØÏþÁᣬÏô»ÀÃ÷£¬Ð»Óñ±¦.ÈÚÈëÖÐÒ½ÎÄ»¯ÄÚº­£¬Ìá¸ßÖÐÒ½Ñо¿ÉúËØÖʽÌÓýˮƽ.Î÷±±Ò½Ñ§½ÌÓý£¬2015£¬23£¨4£©£º671-674
ʩ÷½ã£¬Õų¯Õ飬³ØÏþÁᣨͨѶ×÷Õߣ©£¬Ð»Óñ±¦£¬Ïô»ÀÃ÷.¸Î»î×éÖ¯¼ì²éÈ·ÕïÒÒÐ͸ÎÑ׸ÎÓ²»¯µÄÁÙ´²¸ßΣÒòËØ·ÖÎö[J].ÁÙ´²¸Îµ¨²¡ÔÓÖ¾£¬2014£¬30£¨2£©£º149-152.
Ö÷ÒªÂÛÎÄ
·¢±íÎÄÕÂ160ƪ£¬ÁоÙÈçÏ£º
Xiao-lingChi*,Huan-mingXiao,Yu-baoXie,Gao-shuCai,Jun-minJiang,Guang-junTian,Mei-jieShi,Shu-duoWu,Peng-taoZhaoandHui-junChen.ProtocolofaprospectivestudyforthecombinationtreatmentofShu-Gan-jian-Pidecoctionandsteroidstandardtherapyinautoimmunehepatitispatients.BMCComplementaryandAlternativeMedicine2016,16:505(DOI10.1186/s12906-016-1486-1)£¨IF1.987£©
Xiao-LingChi,Mei-JieShi,Huan-MingXiao,Yu-BaoXie,andGao-ShuCai.ThescoremodelcontainedChinesemedicinesyndromeelementofbloodstasispresentedaabetterperformancecomparedtoAPRIandFIB4indiagnosingadvancedfibrosisinpatientswithChronicHepatitisB.Evidence-BasedcomplementaryandAlternativeMedicine(IF1.88)£¨Volume2016,ArticleID**,6pageshttp://dx.doi.org/10.1155/2016/**£©
XiaoHuanming,JiangJunmin,XieYubao,ShiMeijie,TianGuangjun,ZhaoPengtao,ZhangChaozhen,ChenHuijun,XuChanyuan,ChiXiaoling.ColonhydrotherapyplusTraditionalChineseMedicinetotreatnon-alcoholicfattyliverdisease:apilotstudy.JournalofTraditionalChineseMedicine.2017,June15,37(3):1-2(IF0.991)
4.XiaoL.Chi,HuanM.Xiao,YuB.Xie,JunM.Jiang,GuangJ.Tian,GaoS.Cai,ShuD.Wu,JieZ.Chen,MeiJ.Shi,ChaoZ.Zhang,PengT.Zhao,HuiJ.Chen,YingX.Li,HongC.Liang,ChanY.Xu.ProgressionofinitiallymildhepaticfibrosisinChronichepatitisBpatients:aprospectiverepeatliverbiopsystudy.HEPATOLOGY,2016,VOLUME63,NUMBER1(SUPPL):883A£¨IF11.711£©
лÓñ±¦£¬³ØÏþÁᣨͨѶ×÷Õߣ©£¬Ïô»ÀÃ÷£¬Ê©Ã·½ã£¬²Ì¸ßÊõ£¬Õų¯Õ飬·®ÕýÂ×.»ùÓÚÔËÆøѧ˵̽ÌÖ¶¡ÓÏÄê¸ÎÏËά»¯µÄ×ۺϷÀÖιæÂÉ.ÖлªÖÐÒ½Ò©ÔÓÖ¾£¬2017£¬32£¨6£©£º2449-2452
ÀèÓ¢ÏÍ£¬ÎâÏþ¾Õ£¬³ØÏþÁᣨͨѶ×÷Õߣ©£¬Ïô»ÀÃ÷£¬Ìï¹ã¿¡.˲ʱµ¯ÐÔ³ÉÏñ¼¼ÊõºÍѪÇåѧÆÀ·ÖÄ£ÐÍÓë¸ÎÏËά»¯³Ì¶ÈµÄÏà¹ØÐÔ[J].¹ã¶«Ò½Ñ§£¬2017£¬38£¨13£©£º1994-1997.
ʩ÷½ã£¬½¯¿¡Ãñ£¬²Ì¸ßÊõ£¬Ìï¹ã¿¡£¬Ð»Óñ±¦£¬Ïô»ÀÃ÷£¬ÕÔÅóÌΣ¬³Â»Ý¾ü£¬³ØÏþÁᣨͨѶ×÷Õߣ©.ÖÐÒ©¹à³¦Í˻Ʒ½¶ÔÖضȻÆð㻼ÕßÍË»Æ×÷ÓõÄÓ°Ïì[J].ÖÐÎ÷Ò½½áºÏ¸Î²¡ÔÓÖ¾£¬2016£¬26£¨3£©£º155-157.
ÀîÔóÅô£¬³ØÏþÁᣨͨѶ×÷Õߣ©£¬ÖÜÏþÁᣬÏô»ÀÃ÷.»ùÓڹż®ÕûÀíµÄÖ¬·¾¸ÎÀú´ú·½Ò©Ö¤ÖηÖÎö[J].ÖлªÖÐÒ½Ò©ÔÓÖ¾£¬2016£¬31£¨10£©£º4307-4308.
Õų¯Õ飬Ïô»ÀÃ÷£¬Ê©Ã·½ã£¬ÎºÔó»Ô£¬Íõ¼ÎºÀ£¬³ØÏþÁᣨͨѶ×÷Õߣ©.ÂýÐÔÒÒÐ͸ÎÑ×Âý²¡¹ÜÀíÖÐҽģʽ³õ̽[J].ÖÐÎ÷Ò½½áºÏ¸Î²¡ÔÓÖ¾£¬2016£¬26£¨3£©£º181-182+184.
Ïô»ÀÃ÷£¬Ð»Óñ±¦£¬Îâ»Ý¾ý£¬³ØÏþÁᣨͨѶ×÷Õߣ©.ºÍºÏÊèÑø·½ÖÎÁÆʵÑéÐÔ´óÊó¸ÎÏËά»¯µÄÁ¿Ð§¹ØϵÑо¿.ÁÉÄþÖÐÒ½Ò©´óѧѧ±¨£¬2016£¬18£¨4£©£º125-128
лÓñ±¦£¬Ïô»ÀÃ÷£¬Ê©Ã·½ã£¬³ØÏþÁᣨͨѶ×÷Õߣ©.¸ÎÏËά»¯µÄÖÐÒ½Ò©ÖÎÁƽøÕ¹[J].ʱÕä¹úÒ½¹úÒ©£¬2016£¬27£¨3£©£º703-706.
³ØÏþÁᣬÀèʤ£¬Ïô»ÀÃ÷£¬Õų¯Õ飬ÁõÑàÑ࣬κÔó»Ô£¬Íõ¼ÎºÀ£¬ÁõÀÖöÎ.69Àý×ÔÉíÃâÒßÐÔ¸ÎÑ×»¼ÕßÖÐÒ½ÌåÖÊÌصã·ÖÎö[J].ÖÐÒ½ÔÓÖ¾£¬2016£¬57£¨6£©£º492-495.
лÓñ±¦£¬³ØÏþÁᣨͨѶ×÷Õߣ©£¬Ïô»ÀÃ÷£¬Ê©Ã·½ã£¬²Ì¸ßÊõ£¬Õų¯Õ飬·®ÕýÂ×£¨Ö¸µ¼£©.´ÓÔËÆøѧ˵̽ÌÖ±ûÉêÄê¸ÎÏËά»¯µÄ×ۺϷÀÖιæÂÉ.ÖлªÖÐÒ½Ò©ÔÓÖ¾£¬2016£¬31£¨3£©£º766-769
³ØÏþÁᣬÏô»ÀÃ÷£¬Ð»Óñ±¦.ÁÙ´²ÖÐҽѧÉúËØÖÊÅàÑøµÄ˼¿¼Óëʵ¼ù.ºÚÁú½­½ÌÓý£¬2016£¬£¨1£©£º73-74
ÁõÑàÑ࣬³ØÏþÁᣨͨѶ×÷Õߣ©£¬Ð»Óñ±¦£¬Ïô»ÀÃ÷.ÊÜ¿ØË¥¼õ²ÎÊý¶Ô·Ç¾Æ¾«ÐÔÖ¬·¾¸Î²¡Àíѧ·Ö¶ÈµÄÕï¶Ï¼ÛÖµ.ÊÀ½ç»ªÈËÏû»¯ÔÓÖ¾£¬2015£¬£¨21£©£º5377-5382
Ïô»ÀÃ÷£¬³ØÏþÁᣨͨѶ×÷Õߣ©£¬½¯¿¡Ãñ£¬Ìï¹ã¿¡£¬Ð»Óñ±¦£¬ÕÔÅóÌΣ¬ÀèÓ¢ÏÍ£¬Ê©Ã·½ã£¬Õų¯Õ飬µËÑàÃÃ.´ÓÖÐÒ½ÍâÖÎÁÆ·¨µÄʵʩ̽Ë÷¸Î²¡×¨¿ÆÖÐÒ½ÌØÉ«ÓÅÊƽ¨Éè[J].ÖÐÒ½Ò©¹ÜÀíÔÓÖ¾£¬2015£¬23£¨20£©£º14-16.
³ØÏþÁᣬÏô»ÀÃ÷£¬Ð»Óñ±¦£¬Ê©Ã·½ã.»ùÓÚÖØ´ó¿ÆÑÐÏîĿ̽ÌÖÖÐÎ÷Ò½½áºÏҽѧÑо¿ÉúµÄÅàÑø.ÖлªÒ½Ñ§½ÌÓý̽Ë÷£¬2015£¬14£¨7£©£º698-701
³ØÏþÁᣬÏô»ÀÃ÷£¬Ð»Óñ±¦.ÈÚÈëÖÐÒ½ÎÄ»¯ÄÚº­£¬Ìá¸ßÖÐÒ½Ñо¿ÉúËØÖʽÌÓýˮƽ.Î÷±±Ò½Ñ§½ÌÓý£¬2015£¬23£¨4£©£º671-674
ʩ÷½ã£¬Õų¯Õ飬³ØÏþÁᣨͨѶ×÷Õߣ©£¬Ð»Óñ±¦£¬Ïô»ÀÃ÷.¸Î»î×éÖ¯¼ì²éÈ·ÕïÒÒÐ͸ÎÑ׸ÎÓ²»¯µÄÁÙ´²¸ßΣÒòËØ·ÖÎö[J].ÁÙ´²¸Îµ¨²¡ÔÓÖ¾£¬2014£¬30£¨2£©£º149-152.